Loss of CADM1 expression is associated with poor prognosis and brain metastasis in breast cancer patients.
Wikman H, Westphal L, Schmid F, Pollari S, Kropidlowski J, Sielaff-Frimpong B, Glatzel M, Matschke J, Westphal M, Iljin K, Huhtala H, Terracciano L, Kallioniemi A, Sauter G, Müller V, Witzel I, Lamszus K, Kemming D, Pantel K.
Wikman H, et al. Among authors: huhtala h.
Oncotarget. 2014 May 30;5(10):3076-87. doi: 10.18632/oncotarget.1832.
Oncotarget. 2014.
PMID: 24833255
Free PMC article.